Market Cap | ₹35,034Cr |
ROE | 12.60% |
P/E Ratio(TTM) | 45.00 |
EPS(TTM) | 30.69 |
P/B Ratio | 5.04 |
Dividend Yield | 0.29% |
Industry P/E | 34.34 |
Book Value | 273.88 |
Debt to Equity | 0.20 |
Face Value | 1 |
Parent Organisation | Ipca Laboratories |
Managing Director | Mr. Pranay Godha |
NSE Symbol | IPCALAB |
FUND NAME | AUM(%) |
---|---|
DSP Healthcare Fund Direct Growth | 7.84% |
DSP Focused Direct Plan Growth | 4.22% |
HDFC Mid Cap Fund Direct Growth | 3.07% |
Kotak Midcap Fund Direct Growth | 3.06% |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Sun Pharmaceutical Industries | NA (0.00%) | 36.87 | ||
Cipla | NA (0.00%) | 23.81 | ||
Dr Reddy's Laboratories | NA (0.00%) | 18.55 | ||
Mankind Pharma | NA (0.00%) | 53.89 |